Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 12Nasopharyngeal Carcinoma 8Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Squamous Cell Carcinoma of Head and Neck 5Esophageal Neoplasms 5Recurrence 4Nasopharyngeal Neoplasms 4Lung Neoplasms 4Carcinoma, Hepatocellular 4Urinary Bladder Neoplasms 3Stomach Neoplasms 3Ovarian Neoplasms 3Osteosarcoma 3Neuroblastoma 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Squamous Cell 3Small Cell Lung Carcinoma 2Peritoneal Neoplasms 2Neoplasms 2Hyperthermia 2Fallopian Tube Neoplasms 2Cholangiocarcinoma 2Central Nervous System Neoplasms 2Breast Neoplasms 2Vulvar Neoplasms 1Vomiting 1Virus Diseases 1Tumor Virus Infections 1Tongue Neoplasms 1

Interventions

Transurethral Resection of Bladder 1Therapeutics 1Referral and Consultation 1Radiotherapy 1Eucalyptus Oil 1Drug Therapy 1Coal Tar 1Cisplatin 1CP protocol 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Paranasal Sinus Neoplasms × Cisplatin × Clear all
NCT00347256 2008-12-10

Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer

University of Tennessee

Phase NA Withdrawn
60 enrolled

Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡